A novel risk score(MCCT)to guide decision for treatment of advanced hepatocellular carcinoma with tr

来源 :第五届广州国际肿瘤学会议暨第一届中国抗癌协会肿瘤靶向治疗专业委员会年会 | 被引量 : 0次 | 上传用户:TSNT1234
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background: Transarterial chemoembolisation(TACE)is still widely used to treat patients with advanced hepatocellular carcinoma who have no access to sorafenib in Asia.However,the indication of TACE for these patients has yet to be established.We established an objective point score to guide this decision in patients with advanced-stage hepatocellular carcinoma.
其他文献
Background: Deregulation of the hepatocyte growth factor(HGF)/MET pathway has been implicated in gastric cancer(GC),representing a potential target in gastric or gastroesophageal junction(G/GEJ)cancer
会议
Objective: This study aimed to assess the predictive and prognostic value of PD-1 expression in tumor infiltrating lymphocytes among hepatocellular carcinoma(HCC)patients treated with cytokine-induced
会议
Background: Voltage gated sodium channel Nav1.5 has been reported potentially promoting metastatic development in colon cancer(CC)cells.To date,the clinical and molecular relevance of Nav1.5 expressio
Background: Tumor response to preoperative chemoradiotherapy(CRT)and postoperative survival outcome have been shown variance among locally advanced rectal cancer(LARC)individuals.Our study aimed to fi
Background: Transarterial chemoembolization(TACE)is currently the first-line treatment for patients with intermediate(BCLC stage B)hepatocellular carcinoma(HCC).However,the prognosis of patients with
Background: RFA is currently a curative therapy for patients with hepatocellular carcinoma(HCC)within Milan criteria.As a downstaging procedure,transarterial chemoembolization(TACE)is a way to reduce
Background: Locally advanced pancreatic cancer(LAPC)patients have a very poor prognosis and limited options for disease control.Local ablation technologies based on thermal damage have been used for t
Purpose: Our study aimed to explore the relationship between mismatch repair(MMR)status and clinicopathological characteristics in Chinese patients with colorectal cancer(CRC).Patients and methods: A
Objective: Results from publications of Kangai injection+FOLFIRI strategy on colorectal cancer are not consistent.We aimed to determine whether the benefits of Kangai injection+FOLFIRI strategy outwei